Copyright
©The Author(s) 2021.
World J Gastroenterol. Jul 28, 2021; 27(28): 4653-4666
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4653
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4653
Table 2 Application of cyclooxygenase-2 inhibitors in cancer
Drug | Cancer type | Effect(s) | Mechanism | Ref. |
Celecoxib | Gastric | Inhibits tumor growth | Increases CD206 and activates macrophages | Thiel et al[46] |
Aspirin | Gastric | Induces apoptosis; inhibits proliferation; inhibits angiogenesis | Acetylates the active site of COX-2;inhibits PG synthesis; activates caspase-8/Bid and caspase-3 | Liu et al[57], and Niikura et al[78] |
Oxadiazole 10c | Colon | Increases antitumor activity; increases sensitivity | Docked into the COX-2 bind site | El-Husseiny et al[79] |
Celecoxib and platinum | Gastric | Prolong overall survival and progression-free survival | - | Guo et al[80] |
Celecoxib and rapamycin | Gastric | Increase sensitivity | Inhibit PI3K/AKT pathway | Cao et al[81] |
Celecoxib and FOLFOX4 | Gastric | Inhibit angiogenesis | Down-regulate VEGF level | Tołoczko-Iwaniuk et al[82] |
Celecoxib and erlotinib | Colorectal | Reduce angiogenesis; inhibit formation; inhibit expansion | Inhibit EGFR signaling | Roberts et al[83] |
Celecoxib and Curcumin | Hepatocellular | Inhibit angiogenesis; inhibit proliferation; induce apoptosis | Inhibit Akt/NF-κB/PGE2/ROS pathway; inhibit COX-2/PGE2 pathway | Abdallah et al[84] |
Sorafenib and meloxicam | Hepatocellular | Inhibit tumor cell growth; inhibit proliferation; enhance apoptosis | Activate endoplasmic reticulum stress; enhance the cytotoxicity | Zhong et al[85] |
Ferrocene derivatives | Breast/cervical | Suppress tumor growth; increase antiproliferative activity; induce apoptosis | Increase the levels of cytotoxicity and reactive oxygen species; reduce the level of PGE2 | Ren et al[86], and Farzaneh et al[87] |
- Citation: Ji XK, Madhurapantula SV, He G, Wang KY, Song CH, Zhang JY, Wang KJ. Genetic variant of cyclooxygenase-2 in gastric cancer: More inflammation and susceptibility. World J Gastroenterol 2021; 27(28): 4653-4666
- URL: https://www.wjgnet.com/1007-9327/full/v27/i28/4653.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i28.4653